Scancell Holdings Enters $25 Million Loan Facility Deal

MT Newswires · 1d ago
03:32 AM EDT, 09/24/2026 (MT Newswires) -- Scancell Holdings (SCLP.L) entered into a loan agreement worth up to $25 million with certain BlackRock-managed funds and accounts. The four-tranche loan carries an interest rate of 10.50% per annum and can be converted into ordinary shares. The company will use the loan to help support its phase 3 study for iSCIB1 and its planned Nasdaq listing. The clinical immuno-oncology company plans to draw down $7 million, subject to shareholder approval. The rest of the $8 million tranches will be drawn down after finalizing its US listing deals and the clinical site launch of its late-stage study.